In the 2-year, United States clinical trial, the VisAbility™ Micro-Insert System appeared to demonstrate excellent visual outcomes, with almost 90% of eyes achieving a distance corrected near visual acuity (DCNVA) of 20/40 or better at 24 months post-op. Similar results were seen in a trial conducted outside of the United States, with 90% of patients achieving DCNVA of 20/40 or better at 12 months post-op.1


VisAbility Implant System—DCNVA 20/40 or Better1
DCNVA at 40cm

1. Data on file. Refocus Group, Inc.